UWSA1-3 Flashcards
Pathogenesis of pulmonary arterial hypertension
PAH is more common in women than men and is often hereditary (eg, due to BMPR2 mutation). It may also occur sporadically or in the setting of connective tissue disease or HIV infection. The pathogenesis involves thickening of the smooth muscle medial layer and hyperplasia of the intimal layer of small pulmonary arteries and arterioles. Progressive intimal fibrosis takes place in a concentric, “onion skin” form with eventual development of plexiform lesions. Vascular resistance in the pulmonary arterial system is markedly increased, leading to elevated pulmonary arterial pressure.
To compensate for elevated pulmonary arterial pressure, right ventricular hypertrophy develops, often evidenced by right ventricular heave (detected by left parasternal lift) on physical examination. Over time, right-sided heart failure can occur with jugular venous distension, hepatomegaly, and peripheral edema.
Classification of pulmonary hypertension
Pulmonary arterial Hypertension mutation
BMPR2
Alveolar Hyaline membrane formation
Alveolar hyaline membrane formation occurs in acute respiratory distress syndrome, which typically occurs in the setting of acute illness or trauma
Describe varying uterine fibroids
pedunculated
intracavitary
Intramural
Submucosal
Subserosal
Heavy menses and irregularly enlarged uterus
This patient with heavy menses and an irregularly enlarged uterus likely has uterine leiomyomas (ie, fibroids). Fibroids are common benign tumors composed of uterine smooth muscle cells and fibroblasts. They commonly present in women in their 30s and 40s, and risk factors include African American race, early menarche, and nulliparity.
Although most leiomyomas are asymptomatic, some are associated with pelvic pressure and pain (due to pressure on neighboring structures) or with infertility/pregnancy loss (due to uterine cavity distortion). Heavy menstrual bleeding, the most common fibroid symptom, may result from impaired uterine contractility, increased uterine surface area, and ulceration of the endometrium over a submucosal fibroid. In addition, biochemical vasoactive growth factors expressed by the fibroids cause venous ectasia (dilation). During menstrual shedding, the large-caliber venules overwhelm normal hemostatic mechanisms (platelet aggregation, fibrin deposition, thrombus formation) that control menstrual blood loss. As a result, patients with fibroids, particularly submucosal or intracavitary fibroids, can have significant anemia and require blood transfusion.
Menses of endometrial cancer
Endometrial cancer can present with heavy vaginal bleeding and anemia; those with endometrial cancer typically have irregular, unpredictable menses caused by unopposed endometrial proliferation.
Endometrial polyps
Endometrial polyps are benign, intracavitary overgrowths of the endometrial stroma.
They typically cause intermenstrual bleeding (due to intermittent ulceration and necrosis)
Endometriosis
Endometriosis is the ectopic implantation of endometrial glands and stroma in the abdominopelvic cavity, which can cause pelvic pain, dysmenorrhea, or infertility. However, because the pathology is extrauterine, patients do not typically have heavy menses or uterine enlargement.
Ischemic colitis mechanism
Ischemic colitis is a common cause of lower gastrointestinal hemorrhage in the elderly. Typically, patients present with crampy abdominal pain, tenderness to palpation, and bloody stool. The two primary mechanisms that produce ischemic colitis are hypoperfusion secondary to diminished cardiac output (as seen in cardiac disease or prolonged shock) and occlusion of the bowel vascular supply (as seen with atheroma, thrombosis, or embolism). The weak lower extremity pulses in this patient indicate he likely has extensive atherosclerosis.
Ischemic Colitis histology
Histologic findings depend upon the cause and severity of the ischemia. Initially, mucosal hemorrhage, ecchymoses, and patchy necrosis are seen. If the ischemia persists and the injury extends down into the muscularis, the bowel wall thickens and becomes edematous. Frank blood may enter the bowel lumen. Finally, transmural infarction is observed, which may result in bowel perforation.
“cobblestone mucosa and transmural inflammation”
Crohns Disease
“Crypt abscesses and multiple pseudopolyps”
Ulcerative colitis
"”Macrophages with accumulated PAS-positive granules”
Whipples Disease
Osteogenesis imperfecta mutation
COL1A1 or COL1A2 genes
Osteogenesis imperfecta pathophysiology
This patient’s early-onset osteoporosis and ocular findings are suggestive of osteogenesis imperfecta (OI), a rare inherited disorder characterized by increased bone fragility. OI is most often caused by mutations in the COL1A1 and COL1A2 genes, which encode proteins that form type I collagen. This form of collagen is the predominant structural component of bones, tendons, ligaments, skin, and sclerae
osteogenesis imperfecta S&S
This patient’s early-onset osteoporosis and ocular findings are suggestive of osteogenesis imperfecta (OI), a rare inherited disorder characterized by increased bone fragility. OI is most often caused by mutations in the COL1A1 and COL1A2 genes, which encode proteins that form type I collagen. This form of collagen is the predominant structural component of bones, tendons, ligaments, skin, and sclerae.
The severity of OI varies considerably, ranging from multiple fractures at birth to premature osteoporosis. Other manifestations include short stature, scoliosis, blue sclerae, hearing loss, increased skin and ligament laxity, and easy bruisability. The blue sclerae seen in patients with OI is caused by the decreased collagen content, which makes the sclerae abnormally thin and translucent and allows the underlying choroid to be seen. Blue sclerae are not diagnostic of OI; they can be seen in other rare disorders (eg, progeria, cutis laxa) and can be a normal finding in neonates.
Menkes Syndrome
Impaired intestinal copper transport can result in Menkes syndrome, an X-linked recessive disorder characterized by seizures, intellectual disability, skeletal abnormalities, and brittle hair. Although blue sclerae can be seen in this Menkes syndrome, this patient is female and lacks other findings consistent with this condition.
MCAD deficiency AKA
medium-chain acyl-CoA dehydrogenase deficiency
MCAD Deficiency Pathophysiology
Medium-chain acyl-CoA dehydrogenase deficiency results in hypoketotic hypoglycemia after prolonged fasting with nausea/vomiting, seizure and liver dysfunction likely triggered by decreased food intake in the setting of a viral illness (eg, low-grade fever, rhinorrhea)
Under normal circumstances, a prolonged fast will result in a decrease in insulin and an increase in glucagon, resulting in mobilization of stored energy. Glycogen is degraded during the first 24 hours of a fast. Gluconeogenesis is subsequently used to provide glucose, which is formed from metabolic intermediates (eg, glycerol, lactate, alpha-ketoacids) derived from the breakdown of protein and fatty acids.
Fatty acids are degraded during fasting to form ketone bodies, which may be used as an alternate source of energy by most tissues. Beta-oxidation is a four-step process that results in the sequential removal of two-carbon units (acetyl-CoA) from fatty acids. The first step is catalyzed by acyl-CoA dehydrogenase. When the amount of acetyl-CoA produced exceeds the capacity of the tricarboxylic acid (TCA) cycle, the excess acetyl-CoA is shunted into the production of ketone bodies (eg, acetoacetate, 3-hydroxybutyrate, acetone). In normal individuals, blood ketone levels are significantly increased within the first few days of a fast.
Acetyl CoA caboxylase is involved in
Acetyl-CoA carboxylase catalyzes the first step in fatty acid synthesis and is the major site of regulation of fatty acid synthesis
Glucose-6-phosphatase is involved in
Glucose-6-phosphatase dephosphorylates glucose-6-phosphate to free glucose, which is released into the circulation during glycogenolysis and gluconeogenesis.
Glucose-6-phosphatase deficiency (glycogen storage disease type I [Von Gierke disease]) results in fasting hypoglycemia and excessive accumulation of glycogen in the liver and kidneys
Glucose-6-phosphatase deficiency causes
Glucose-6-phosphatase deficiency (glycogen storage disease type I [Von Gierke disease]) results in fasting hypoglycemia and excessive accumulation of glycogen in the liver and kidneys
Glycogen phosphorylase deficiency
Glycogen phosphorylase is responsible for cleaving the alpha-1,4 glycosidic linkage between glucose residues in glycogen, thereby liberating glucose-1-phosphate. Deficiency of this enzyme in skeletal muscle results in glycogen storage disease type V (McArdle disease). This condition typically presents with exercise intolerance and muscle pain.
A 53-year-old woman is diagnosed with a metastatic brain tumor after developing new-onset, generalized tonic-clonic seizures. Several of her family members also have a history of cancer. The location of the primary tumor is determined and appropriate management is initiated. Further studies reveal that this patient is predisposed to malignancy as a result of a genetic alteration in a protein that functions to transduce signals from the cell membrane to the nucleus by activating other molecules. Which of the following proteins is most likely defective in this patient?
Ras
Ras function
Ras is an oncoprotein (ie, protein encoded by a proto-oncogene) component of the MAP-kinase signal transduction system. It is present in an inactive (GDP-containing) or an active (GTP-containing) form. The phosphorylated, active Ras protein transmits a stimulus from the receptor on the cell surface into the nucleus, promoting mitogenesis. Up to 20% of all human tumors contain mutated Ras proteins that have reduced GTPase activity (leading to less GTP degradation); as a result, these mutated Ras proteins remain in an excited GTP-containing state (gain of function), stimulating neoplastic growth through continuous pathologic activation of the mitogenic signaling pathway.
BRAF gene type
Proto-oncogene (1-hit gain of function)
Ras signal transduction
ABL gene type
Proto-oncogene (1-hit gain of function)
Non-receptor tyrosine kinase
ERBB2 AKA
HER2
ERBB2 gene type
Proto-oncogene (1-hit gain of function)
Receptor tyrosine kinase
AKA HER2
ERBB1 AKA
EGFR
ERBB1 gene type
Proto-oncogene (1-hit gain of function)
Receptor Tyrosine kinase
AKA EGFR
MYC gene type
Proto-oncogene (1-hit gain of function)
Transcription factor
RAS gene type
Proto-oncogene (1-hit gain of function)
GTP binding protein
BRCA 1 gene type
Tumor suppressor gene (requires 2-hit loss of function)
DNA Repair gene
BRCA 2 gene type
Tumor suppressor gene (requires 2-hit loss of function)
DNA repair gene
APC/β-cateinin gene type
Tumor suppressor gene (requires 2-hit loss of function)
WNT signaling pathway
TP53 gene type
Tumor suppressor gene (requires 2-hit loss of function)
Genomic Stability
RB gene type
Tumor suppressor gene (requires 2-hit loss of function)
(G1/S transition inhibitor) GTP
WT1 gene type
Tumor suppressor gene (requires 2-hit loss of function)
Urogenital differentiation
VHL gene type
Tumor suppressor gene (requires 2-hit loss of function)
Ubiquitin ligase component
INR interpretation
When the INR is higher than the recommended range, it means that your blood clots more slowly than desired, and a lower INR means your blood clots more quickly than desired
Features of a Lineweaver-Burke Plot
In this example, rifampin use will increase CYP2C9 concentration within hepatocytes. This increaseinenzyme concentration leads to an increase in hepatic warfarin metabolism and a corresponding rise inVmax. Because the y-intercept in a Lineweaver-Burke plot is 1/Vmax, an increase in Vmax would lowerthey-intercept. Enzyme induction increases the expression of an enzyme but does not change its affinity for substrate (Km), so the x-intercept (-1/Km) would remain unchanged.
A 68-year-old man on warfarin therapy after a mechanical valve replacement develops a rapid decrease in INR after starting rifampin. Rifampin induces synthesis of CYP2C9, a cytochrome P450 enzyme in hepatocytes, leading to increased warfarin metabolism. Which of the following plots most likely represents the change in CYP2C9 enzyme kinetics with regard to warfarin metabolism? (Solid line, original state; dashed line, change in kinetics)
In this example, rifampin use will increase CYP2C9 concentration within hepatocytes. This increaseinenzyme concentration leads to an increase in hepatic warfarin metabolism and a corresponding rise inVmax. Because the y-intercept in a Lineweaver-Burke plot is 1/Vmax, an increase in Vmax would lowerthey-intercept. Enzyme induction increases the expression of an enzyme but does not change its affinity for substrate (Km), so the x-intercept (-1/Km) would remain unchanged.
Histology of pulmonary carcinoid Tumor
Pulmonary carcinoid tumor arises from enterochromaffin (Kulchitsky) cells in the bronchial epithelium. It is composed of uniform, polygonal cells with eosinophilic cytoplasm and granular (ie, salt and pepper) chromatin
Lung mass expressing Chromogranin and Synaptophysin
This patient has a lung mass expressing neuroendocrine markers (eg, chromogranin, synaptophysin), consistent with a pulmonary neuroendocrine tumor (NET). The spectrum of pulmonary NETs ranges from carcinoid (well differentiated) to small cell carcinoma (poorly differentiated). In this young nonsmoker, carcinoid tumor is most likely.
Pulmonary carcinoid tumor arises from enterochromaffin (Kulchitsky) cells in the bronchial epithelium. It is composed of uniform, polygonal cells with eosinophilic cytoplasm and granular (ie, salt and pepper) chromatin. The tumor typically forms in proximal airways and grows endobronchially, explaining its frequent presentation with obstruction (eg, unilateral wheezing, recurrent pneumonia) or tumor bleeding (eg, hemoptysis).
Carcinoid tumors may secrete vasoactive mediators (eg, serotonin, vasoactive intestinal peptide), which can provoke episodes of cutaneous flushing and secretory diarrhea (ie, carcinoid syndrome). Pulmonary carcinoid tumors produce lower mediator levels than their midgut counterparts, so florid carcinoid syndrome is quite rare.
Small cell lung carcinoma is another pulmonary NET that arises in the proximal airways; however, it occurs almost exclusively in older smokers, grows invasively to infiltrate the basal lamina (eg, metastases, weight loss), and can cause a variety of paraneoplastic syndromes (eg, Lambert-Eaton syndrome).
Medullary Thyroid Carcinoma Histology
Renal cell carcinoma Histology
Pheochromocytoma Histology
Lung Squamous Cell Carcinoma Histology
Gram positive vs Gram negative bacteria structure
Internal Ribosome Entry Site
Eukaryotic translation is initiated when the small ribosomal subunit binds the 5’ cap of mRNA and scans for the methionine start codon (AUG) within the Kozak consensus sequence. Ribosomal binding to the 5’ cap is facilitated by a family of proteins known as eukaryotic initiation factors (eIFs).
During programmed cell death (apoptosis), the activation of caspases results in eIF degradation, leading to interruption of translation. As a result, many of the proteins necessary for apoptosis are translated using an alternative method known as internal ribosome entry. With this method, a distinct nucleotide sequence called the internal ribosome entry site (IRES) attracts the eukaryotic ribosome to mRNA and allows translation to begin in the middle of the mRNA sequence. IRESs are usually located in the 5’ untranslated region, the segment of mRNA located directly upstream from the translation start codon
Thiazolidinedione MOA
Thiazolidinediones (TZDs) (eg, pioglitazone) are oral antidiabetic medications that exert their glucose-lowering effects by decreasing insulin resistance. They activate peroxisome proliferator-activated receptor gamma (PPAR-γ), a nuclear receptor that modulates genes involved in lipid and glucose metabolism. Important proteins that are upregulated by TZDs include:
glucose transporter-4, an insulin-responsive, transmembrane glucose transporter expressed in adipocytes and skeletal myocytes that increases glucose uptake by target cells
adiponectin, a cytokine secreted by fat tissue that lowers triglyceride levels by inducing differentiation of preadipocytes into insulin-responsive adipocytes and stimulating fatty acid oxidation
Because TZDs do not promote pancreatic beta-cell insulin release, they do not cause hypoglycemia. The main side effects are fluid retention (with possible worsening of congestive heart failure) and weight gain.
A 46-year-old woman with type 2 diabetes mellitus comes to the clinic for a follow-up appointment. She was diagnosed with diabetes 5 years ago and has been treated with metformin. Over the last year, her glycemic control has worsened despite good compliance with diet, exercise, and medication. Laboratory results show a fasting glucose level of 185 mg/dL and hemoglobin A1c of 8.0%. After discussing medication options, the patient agrees to the addition of an oral antidiabetic medication that induces differentiation of preadipocytes into adipocytes and increases glucose transporter-4 expression on the adipocyte cell membrane. Which of the following agents was most likely chosen for this patient?
Pioglitazone
Thiazolidinediones (TZDs) (eg, pioglitazone) are oral antidiabetic medications that exert their glucose-lowering effects by decreasing insulin resistance. They activate peroxisome proliferator-activated receptor gamma (PPAR-γ), a nuclear receptor that modulates genes involved in lipid and glucose metabolism. Important proteins that are upregulated by TZDs include:
glucose transporter-4, an insulin-responsive, transmembrane glucose transporter expressed in adipocytes and skeletal myocytes that increases glucose uptake by target cells
adiponectin, a cytokine secreted by fat tissue that lowers triglyceride levels by inducing differentiation of preadipocytes into insulin-responsive adipocytes and stimulating fatty acid oxidation
Adverse effects of Thiazolidinediones
main side effects are fluid retention (with possible worsening of congestive heart failure) and weight gain
Acarbose MOA
Acarbose is an intestinal brush border alpha-glucosidase inhibitor that decreases postprandial hyperglycemia by reducing gastrointestinal absorption of polymeric glucose
SGLT-2 Inhibitors
Sodium-glucose cotransporter-2 inhibitors (eg, canagliflozin, dapagliflozin) act in the kidney to decrease reabsorption of filtered glucose.
Sulfonylureas MOA
Sulfonylureas (eg, glyburide) and meglitinides (eg, repaglinide) bind to and close the ATP-sensitive K+ channel in the pancreatic beta-cell membrane, inducing depolarization and L-type calcium channel opening. The increased Ca2+ influx stimulates insulin release.
Meglitinides MOA
Sulfonylureas (eg, glyburide) and meglitinides (eg, repaglinide) bind to and close the ATP-sensitive K+ channel in the pancreatic beta-cell membrane, inducing depolarization and L-type calcium channel opening. The increased Ca2+ influx stimulates insulin release.
Same mechanism as sulfonylureas but with less affinity and are shorter-acting so carry less risk of post-prandial hypoglycemia
Meglitinides examples
repaglinide
Clinical manifestations of Crohns Disease
Crohn disease is a chronic, idiopathic, inflammatory condition that classically presents with abdominal pain, diarrhea, and low-grade fever. Aphthous ulcers of the mouth, as in this patient, may also be observed. Bowel obstruction, fistulae, or perianal disease (eg, fissures, abscesses) eventually develops in most individuals due to transmural inflammation of the intestinal wall. Although any area of the gastrointestinal tract may be affected, the most frequently involved site is the terminal ileum.
Most common area afflicted in Crohns Disease
Although any area of the gastrointestinal tract may be affected, the most frequently involved site is the terminal ileum.
What is this?
Aphthous ulcers of the mouth found in Crohns Disease
Area most afflicted in Celiac Disease
distal duodenum and proximal jejunum
Chronic Atrophic Gastritis vs Chronic Antral Gastritis
Chronic atrophic gastritis is characterized by chronic inflammation of the gastric body/fundus due to autoimmune parietal cell destruction, whereas chronic antral gastritis is typically associated with Helicobacter pylori infection.
List of CYP 450 Inhibitors
- Antibiotics (eg, metronidazole, macrolides, TMP-SMX)
- Azole antifungals
- Amiodarone
- Cimetidine
- Grapefruit juice
leads to ↑ Warfarin effect
(↑ bleeding risk)
List of CYP 450 Inducers
- Carbamazepine
- Phenytoin
- Phenobarbital
- Rifampin
- St. John’s wort
↓ Warfarin effect
(↓ in efficacy)
aPTT coagulation pathway
Intrinsic
Pt measures which coagulation pathway
Intrinsic
Warfarin primarily affects which coagulation pathway
Intrinsic PT
Heparin affects which coagulation pathway
Extrinsic aPTT
High INR interpretation
When the INR is higher than the recommended range, it means that your blood clots more slowly than desired
Lactulose Treatment of Hepatic encephalopathy
in cirrhosis, NH3 metabolism is reduced in the liver leading to increased systemic NH3 levels which cause Neuropsychiatric abnormalities (sleep disturbances and mood changes)
When Txed with Lactulose, it is converted to lactic and acetic acid which decreases the colon pH favoring the formation of NH4+ which is not absorbed and can be secreted reducing overall levels of NH3 and symptoms improve
S&S of Hepatic encephalopathy
In a patient with severe liver dysfunction; the acute onset of confusion; sleep disturbances; and jerky, involuntary hand movements with dorsiflexion (ie, asterixis) are concerning for hepatic encephalopathy. (caused by reduced NH3 metabolism in the liver and increased systemic NH3
Crystalloid infusion
Crystalloid infusion is useful in the fluid resuscitation of hypovolemic individuals but would likely only exacerbate the edema and ascites in a cirrhotic patient
portacaval shunting
Immediate portacaval shunting would likely worsen the hepatic encephalopathy because it would redirect the ammonia-rich portal blood into circulation without any hepatic processing
α1 stimulation change in second messenger
Increased IP3